These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9364682)
21. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120. Nehete PN; Casement KS; Arlinghaus RB; Sastry KJ Cell Immunol; 1995 Feb; 160(2):217-23. PubMed ID: 7720083 [TBL] [Abstract][Full Text] [Related]
22. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Men Y; Tamber H; Audran R; Gander B; Corradin G Vaccine; 1997; 15(12-13):1405-12. PubMed ID: 9302752 [TBL] [Abstract][Full Text] [Related]
23. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 2. Mode of action of the w/o/w emulsion. Kimura J; Nariuchi H; Watanabe T; Matuhasi T Jpn J Exp Med; 1978 Jun; 48(3):203-9. PubMed ID: 309525 [TBL] [Abstract][Full Text] [Related]
24. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Lasarte JJ; Sarobe P; Gullón A; Prieto J; Borrás-Cuesta F Cell Immunol; 1992 Apr; 141(1):211-8. PubMed ID: 1532538 [TBL] [Abstract][Full Text] [Related]
25. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
26. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. Grufman P; Sandberg JK; Wolpert EZ; Kärre K J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165 [TBL] [Abstract][Full Text] [Related]
27. CpG-mediated augmentation of CD8+ T-cell responses in mice is attenuated by a water-in-oil emulsion (Montanide ISA-51) but enhanced by an oil-in-water emulsion (IDRI SE). Makinen SR; Zhu Q; Davis HL; Weeratna RD Int Immunol; 2016 Sep; 28(9):453-61. PubMed ID: 27055469 [TBL] [Abstract][Full Text] [Related]
29. Flt3 ligand and conjugation to IL-1beta peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine. Pisarev VM; Parajuli P; Mosley RL; Chavez J; Zimmerman D; Winship D; Talmadge JE Vaccine; 2002 May; 20(17-18):2358-68. PubMed ID: 12009292 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the adjuvant activity of emulsions with different physicochemical properties on the antibody response towards the venom of West African carpet viper (Echis ocellatus). Valverde JM; Rodríguez K; Herrera M; Segura Á; Vargas M; Villalta M; Montero M; Gutiérrez JM; León G Toxicon; 2017 Mar; 127():106-111. PubMed ID: 28088478 [TBL] [Abstract][Full Text] [Related]
31. A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery. Yoshioka T; Skalko N; Gursel M; Gregoriadis G; Florence AT J Drug Target; 1995; 2(6):533-9. PubMed ID: 7773616 [TBL] [Abstract][Full Text] [Related]
32. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens. Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638 [TBL] [Abstract][Full Text] [Related]
33. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice. Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226 [TBL] [Abstract][Full Text] [Related]
34. The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice. Harris SJ; Woodrow SA; Gearing AJ; Adams SE; Kingsman AJ; Layton GT Vaccine; 1996 Jul; 14(10):971-6. PubMed ID: 8873390 [TBL] [Abstract][Full Text] [Related]
35. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862 [TBL] [Abstract][Full Text] [Related]
36. P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Shariat S; Badiee A; Jalali SA; Mansourian M; Yazdani M; Mortazavi SA; Jaafari MR Cancer Lett; 2014 Dec; 355(1):54-60. PubMed ID: 25224570 [TBL] [Abstract][Full Text] [Related]
37. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. Shirai M; Pendleton CD; Berzofsky JA J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784 [TBL] [Abstract][Full Text] [Related]
38. Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction. Miconnet I; Coste I; Beermann F; Haeuw JF; Cerottini JC; Bonnefoy JY; Romero P; Renno T J Immunol; 2001 Apr; 166(7):4612-9. PubMed ID: 11254719 [TBL] [Abstract][Full Text] [Related]
39. Determination of Mycoplasma hyopneumoniae-Specific IgG, IgG1, and IgG2a Titers in BALB/c Mice Induced by Mineral Oil-Based Oil-in-Water Emulsion Adjuvants Prepared Using a Self-Emulsifying Drug Delivery System. Bastola R; Seo JE; Noh G; Keum T; Kim JH; Shin JI; Lee S; Lee S AAPS PharmSciTech; 2019 Jan; 20(1):31. PubMed ID: 30603786 [TBL] [Abstract][Full Text] [Related]